Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 14, 2015
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Zev A Wainberg, Heloisa P Soares, Ravi Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients
Kazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2007
Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression
Takahiro Kimura, Richard C Koya, Laura Anselmi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial
Kazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma
Steven J O'Day, Michael B Atkins, Peter Boasberg, et al.
Experimental & Molecular Medicine
|
August 23, 2022
Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis
Ran Gao, Wenjun Guo, Tianfei Fan, et al.
Journal of Geriatric Oncology
|
July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis
Peter Ward, J Randolph Hecht, He-Jing Wang, et al.
Cancer Research
|
July 5, 2006
Estrogen receptor-alpha methylation predicts melanoma progression
Takuji Mori, Steve R Martinez, Steven J O'Day, et al.
Gynecologic Oncology
|
March 4, 2008
Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer
Gottfried E Konecny, Rachana Agarwal, Gary A Keeney, et al.
Annals of Surgery
|
December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma
Sojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
Cancer Chemotherapy and Pharmacology
|
May 14, 2015
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Zev A Wainberg, Heloisa P Soares, Ravi Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2006
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients
Kazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2007
Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression
Takahiro Kimura, Richard C Koya, Laura Anselmi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial
Kazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma
Steven J O'Day, Michael B Atkins, Peter Boasberg, et al.
Experimental & Molecular Medicine
|
August 23, 2022
Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis
Ran Gao, Wenjun Guo, Tianfei Fan, et al.
Journal of Geriatric Oncology
|
July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis
Peter Ward, J Randolph Hecht, He-Jing Wang, et al.
Cancer Research
|
July 5, 2006
Estrogen receptor-alpha methylation predicts melanoma progression
Takuji Mori, Steve R Martinez, Steven J O'Day, et al.
Gynecologic Oncology
|
March 4, 2008
Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer
Gottfried E Konecny, Rachana Agarwal, Gary A Keeney, et al.
Annals of Surgery
|
December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma
Sojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Page
of 17